Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2005Viral Immunology

Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJose M. GalarzaTechnova Corporation (United States)TLTheresa LathamNortheastern UniversityACAlbert CupoCornell University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Galarza et al. (2005) studied this question.

synapsesocial.com/papers/6aaa3887274631fa87a88085https://doi.org/10.1089/vim.2005.18.244
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Generation of Influenza A Viruses with Chimeric (Type A/B) Hemagglutinins2003 · 25 citations
  2. 2Ebola virus-like particles protect from lethal Ebola virus infection2003 · 245 citations
  3. 3Origin of the West Nile Virus Responsible for an Outbreak of Encephalitis in the Northeastern United States1999 · 1,621 citations
  4. 4Case‐Control Study of Risk Factors for Avian Influenza A (H5N1) Disease, Hong Kong, 19971999 · 286 citations
  5. 5Quantitative densitometry of proteins stained with Coomassie Blue using a Hewlett Packard scanjet scanner and Scanplot software1997 · 47 citations